Kamis, 11 Juni 2026 - 17:45 WIB

Find and Follow Us

Global Markets

IHSG 5,886.03 -0.28%

S&P 500 7,266.99 -1.62%

NASDAQ 25,169.50 -1.98%

Dow Jones 49,918.78 -1.87%

FTSE 100 10,339.66 +0.83%

CAC 40 8,221.49 +0.73%

Nikkei 225 64,217.27 +0.06%

Hang Seng 24,249.29 -0.65%

Shanghai 3,987.01 -0.16%

KOSPI 7,763.95 +0.43%

STI 4,988.10 +0.59%

ASX 200 8,633.20 -0.23%

Sensex 73,832.55 -0.20%

Gold 4,112.50 +0.10%

Silver 64.15 -0.70%

Oil (WTI) 88.86 -1.30%

Brent 91.69 -1.51%

Copper 6.22 -0.48%

Gas Alam 3.12 -2.17%

Bitcoin 62,854.02 +2.29%

Ethereum 1,654.99 +2.15%

USD/IDR 17,985.00 -0.26%

EUR/USD 1.15 -0.05%

Advertisement

Milan Paleja - General Manager Pharma, President Director, Novartis Group Indonesia

Novartis Hadirkan Pengobatan Baru untuk Psoriasis dengan Secukinumab

Redaksi • 17 Agustus 2017

Latest Updates

- Advertisement -

Milan Paleja - General Manager Pharma, President Director, Novartis Group Indonesia

08:49 WIB • 17 Agustus 2017

Novartis Hadirkan Pengobatan Baru untuk Psoriasis dengan Secukinumab

Novartis Indonesia meluncurkan secukinumab, pengobatan baru bagi pasien psoriasis di Indonesia untuk mendapatkan kondisi…